Fred Jacobs
3 years ago
By Amber Wareing
Share on
CEO and co-founder for biotechnology company TYG Oncology. TYG Oncology is developing treatments for the deadliest of all cancers, pancreatic cancer. Our lead therapeutic product is designed to neutralise gastrin, a known growth factor and risk factor for gastrointestinal cancers like pancreatic cancer, oesophageal cancer and related Barrett’s oesophagus, a precancerous condition and colon and gastric cancers. Roundtable discussion: Predictive analytics: the leveraging of computational techniques to aide in decision-making.
More news